IBDEI0XG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14897,1,3,0)
 ;;=3^Hepatomegaly NEC
 ;;^UTILITY(U,$J,358.3,14897,1,4,0)
 ;;=4^R16.0
 ;;^UTILITY(U,$J,358.3,14897,2)
 ;;=^5019248
 ;;^UTILITY(U,$J,358.3,14898,0)
 ;;=K76.81^^85^836^62
 ;;^UTILITY(U,$J,358.3,14898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14898,1,3,0)
 ;;=3^Hepatopulmonary syndrome
 ;;^UTILITY(U,$J,358.3,14898,1,4,0)
 ;;=4^K76.81
 ;;^UTILITY(U,$J,358.3,14898,2)
 ;;=^340555
 ;;^UTILITY(U,$J,358.3,14899,0)
 ;;=K76.3^^85^836^64
 ;;^UTILITY(U,$J,358.3,14899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14899,1,3,0)
 ;;=3^Infarction of Liver
 ;;^UTILITY(U,$J,358.3,14899,1,4,0)
 ;;=4^K76.3
 ;;^UTILITY(U,$J,358.3,14899,2)
 ;;=^5008833
 ;;^UTILITY(U,$J,358.3,14900,0)
 ;;=R79.89^^85^836^65
 ;;^UTILITY(U,$J,358.3,14900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14900,1,3,0)
 ;;=3^Iron metabolism,Hyperferritinemia
 ;;^UTILITY(U,$J,358.3,14900,1,4,0)
 ;;=4^R79.89
 ;;^UTILITY(U,$J,358.3,14900,2)
 ;;=^5019593
 ;;^UTILITY(U,$J,358.3,14901,0)
 ;;=R79.0^^85^836^66
 ;;^UTILITY(U,$J,358.3,14901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14901,1,3,0)
 ;;=3^Iron metabolism,Iron levels abnormal
 ;;^UTILITY(U,$J,358.3,14901,1,4,0)
 ;;=4^R79.0
 ;;^UTILITY(U,$J,358.3,14901,2)
 ;;=^5019590
 ;;^UTILITY(U,$J,358.3,14902,0)
 ;;=T86.42^^85^836^68
 ;;^UTILITY(U,$J,358.3,14902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14902,1,3,0)
 ;;=3^Liver transplant failure
 ;;^UTILITY(U,$J,358.3,14902,1,4,0)
 ;;=4^T86.42
 ;;^UTILITY(U,$J,358.3,14902,2)
 ;;=^5055726
 ;;^UTILITY(U,$J,358.3,14903,0)
 ;;=T86.43^^85^836^69
 ;;^UTILITY(U,$J,358.3,14903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14903,1,3,0)
 ;;=3^Liver transplant infection
 ;;^UTILITY(U,$J,358.3,14903,1,4,0)
 ;;=4^T86.43
 ;;^UTILITY(U,$J,358.3,14903,2)
 ;;=^5055727
 ;;^UTILITY(U,$J,358.3,14904,0)
 ;;=T86.41^^85^836^70
 ;;^UTILITY(U,$J,358.3,14904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14904,1,3,0)
 ;;=3^Liver transplant rejection
 ;;^UTILITY(U,$J,358.3,14904,1,4,0)
 ;;=4^T86.41
 ;;^UTILITY(U,$J,358.3,14904,2)
 ;;=^5055725
 ;;^UTILITY(U,$J,358.3,14905,0)
 ;;=Z94.4^^85^836^71
 ;;^UTILITY(U,$J,358.3,14905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14905,1,3,0)
 ;;=3^Liver transplant status
 ;;^UTILITY(U,$J,358.3,14905,1,4,0)
 ;;=4^Z94.4
 ;;^UTILITY(U,$J,358.3,14905,2)
 ;;=^5063658
 ;;^UTILITY(U,$J,358.3,14906,0)
 ;;=C22.0^^85^836^58
 ;;^UTILITY(U,$J,358.3,14906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14906,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,14906,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,14906,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,14907,0)
 ;;=J90.^^85^836^76
 ;;^UTILITY(U,$J,358.3,14907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14907,1,3,0)
 ;;=3^Pleural effusion NEC
 ;;^UTILITY(U,$J,358.3,14907,1,4,0)
 ;;=4^J90.
 ;;^UTILITY(U,$J,358.3,14907,2)
 ;;=^5008310
 ;;^UTILITY(U,$J,358.3,14908,0)
 ;;=K74.3^^85^836^80
 ;;^UTILITY(U,$J,358.3,14908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14908,1,3,0)
 ;;=3^Primary biliary cirrhosis
 ;;^UTILITY(U,$J,358.3,14908,1,4,0)
 ;;=4^K74.3
 ;;^UTILITY(U,$J,358.3,14908,2)
 ;;=^5008819
 ;;^UTILITY(U,$J,358.3,14909,0)
 ;;=K76.6^^85^836^77
 ;;^UTILITY(U,$J,358.3,14909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14909,1,3,0)
 ;;=3^Portal hypertension
 ;;^UTILITY(U,$J,358.3,14909,1,4,0)
 ;;=4^K76.6
 ;;^UTILITY(U,$J,358.3,14909,2)
 ;;=^5008834
